Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection
Top Cited Papers
Open Access
- 1 March 2000
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hepatology
- Vol. 31 (3), 792-799
- https://doi.org/10.1002/hep.510310337
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Analysis of the Reversibility of Chronic Liver Allograft Rejection Implications for a Staging Schema*The American Journal of Surgical Pathology, 1999
- EFFICACY OF TACROLIMUS AS RESCUE THERAPY FOR CHRONIC REJECTION IN ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1997
- Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejectionThe Lancet, 1994
- Cell migration, chimerism, and graft acceptanceThe Lancet, 1992
- Cause and timing of first allograft failure in orthotopic liver transplantation: A study of 177 consecutive patientsHepatology, 1991
- Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failureHepatology, 1991
- Chronic rejection after liver transplantation: A study of clinical, histopathological and immunological featuresHepatology, 1991
- VANISHING BILE-DUCT SYNDROME FOLLOWING LIVER TRANSPLANTATION—IS IT REVERSIBLE?Transplantation, 1991
- EVIDENCE THAT THE VANISHING BILE DUCT SYNDROME IS VANISHINGTransplantation, 1990
- FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATIONThe Lancet, 1989